Clinical trials for Polymyalgia rheumatica

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Polymyalgia rheumatica. For all clinical trials, go to clinical trials search

This list shows clinical trials for Polymyalgia rheumatica

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Polymyalgia rheumatica
Title Recruitment status Location
A clinical study, assessing the effect of 2 new drugs (AIN457, ACZ885) as compared to a standard drug (corticosteroids) to relief pain and inflammation in patients with Polymyalgia rheumatica (PMR) Not Recruiting United Kingdom
An open-label, phase II dose titration study of ACZ885 (human anti-IL-1beta monoclonal antibody) to assess the clinical efficacy, safety, pharmacokinetics and pharmacodynamics in patients with NALP3 mutations - A2102 Not Recruiting United Kingdom
A Study of LY2127399 in Patients With Systemic Lupus Erythematosus Not Recruiting United Kingdom
A 2-week study in patients with polymyalgia rheumatica Not Recruiting United Kingdom
Uncontrolled extension trial to protocol AC-052-406 to evaluate the long-term effects of bosentan therapy in patients with pulmonary arterial hypertension related to connective tissue disease (TRUST-Extension) - TRUST - Extension Not Recruiting United Kingdom
An open-label, phase II dose titration study of ACZ885 (human anti-IL-1beta monoclonal antibody) to assess the clinical efficacy, safety, pharmacokinetics and pharmacodynamics in patients with NALP3 mutations - CACZ885A2102 Not Recruiting United Kingdom
Uncontrolled extension trial to protocol AC-052-406 to evaluate the long term effect of bosentan therapy in patient with pulmonary arterial hypertension related to connective tissue disease (TRUST-extension) Not Recruiting United Kingdom
Effect of Sildenafil on Pulmonary Artery Pressure during hypoxia and exercise in Chronic Heart Failure - Effect of sildenafil on PA pressure during exercise and hypoxia in CHF Not Recruiting United Kingdom
An open-label, phase II dose titration study of ACZ885 (human anti-IL-1beta monoclonal antibody) to assess the clinical efficacy, safety, pharmacokinetics and pharmacodynamics in patients with NALP3 mutations - A2102 Not Recruiting United Kingdom
A 2-week single-blind, randomized, 3-arm proof of concept study of the effects of AIN457 (anti-IL17 antibody), ACZ885 (canakinumab, anti-IL1b antibody), or corticosteroids in patients with polymyalgia rheumatica, followed by an open label phase to assess safety and long term efficacy Authorised United Kingdom

Page last reviewed:

Next review due: